BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29954359)

  • 1. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
    Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
    BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma.
    Virchow JC; Rodriguez-Roisin R; Papi A; Shah TP; Gopalan G
    BMC Pulm Med; 2016 Mar; 16():42. PubMed ID: 26987997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.
    Voorham J; Roche N; Benhaddi H; van der Tol M; Carter V; van Boven JFM; Bjermer L; Miravitlles M; Price DB
    BMJ Open; 2018 Oct; 8(10):e022051. PubMed ID: 30368448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combination.
    Roche N; Aguilaniu B; Paternotte S; Dallery N
    J Asthma; 2022 Apr; 59(4):765-774. PubMed ID: 33493074
    [No Abstract]   [Full Text] [Related]  

  • 6. A Comparison of Short-Term Growth During Treatment with Two Dry Powder Combinations of Inhaled Corticosteroids and Long-Acting β₂-Agonists.
    Wolthers OD; Shah T
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):182-8. PubMed ID: 25166221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
    Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
    Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique.
    Cvetkovski B; Hespe C; Tan R; Kritikos V; Azzi E; Bosnic-Anticevich S
    Pulm Ther; 2020 Dec; 6(2):315-331. PubMed ID: 33038005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax® and Turbuhaler® devices: a randomised, cross-over study.
    Azouz W; Chetcuti P; Hosker H; Saralaya D; Chrystyn H
    BMC Pulm Med; 2015 May; 15():47. PubMed ID: 25927483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler
    Syk J; Vinge I; Sörberg M; Vahteristo M; Rytilä P
    Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaler technique mastery and maintenance in healthcare professionals trained on different devices.
    Bosnic-Anticevich S; Callan C; Chrystyn H; Lavorini F; Nikolaou V; Kritikos V; Dekhuijzen PNR; Roche N; Bjermer L; Rand C; Zwar N; Price DB
    J Asthma; 2018 Jan; 55(1):79-88. PubMed ID: 28332886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of budesonide plus formoterol (BF) Spiromax® and BF Turbohaler® (with and without charcoal block) in healthy volunteers.
    Weisfeld L; Shu Y; Shah TP
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):593-602. PubMed ID: 26042485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.
    Bateman ED; Harrison TW; Quirce S; Reddel HK; Buhl R; Humbert M; Jenkins CR; Peterson S; Ostlund O; O'Byrne PM; Sears MR; Eriksson GS
    Respir Res; 2011 Apr; 12(1):38. PubMed ID: 21463522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent bronchodilation with budesonide/formoterol combination via Easyhaler and Turbuhaler in patients with asthma.
    Lähelmä S; Vahteristo M; Metev H; Taseva M; Stamatova N; Bartha A; Schlezák J; Sairanen U
    Respir Med; 2016 Nov; 120():31-35. PubMed ID: 27817813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD.
    Giner J; Villarnovo Cerrillo M; Aboín Sierra J; Casas Herrero L; Patino O; Plaza V
    Eur Clin Respir J; 2020 Oct; 8(1):1833411. PubMed ID: 33144930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial.
    Gillissen A; Gessner C; Hechenbichler K; Herth FJF; Juenemann R; Kanniess F; Kardos P; Lommatzsch M; Schneidereit R; Windisch W
    Respiration; 2019; 97(4):292-301. PubMed ID: 30391944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler).
    Sandler N; Holländer J; Långström D; Santtila P; Saukkonen A; Torvinen S
    BMJ Open Respir Res; 2016; 3(1):e000119. PubMed ID: 27026804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symbicort: controlling asthma in adults.
    Lalloo U
    Respir Med; 2002 Feb; 96 Suppl A():S16-22. PubMed ID: 11858561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An innovative corticosteroid/long-acting β
    Usmani O; Roche N; Marshall J; Danagher H; Price D
    Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
    [No Abstract]   [Full Text] [Related]  

  • 20. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
    Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.